Bio-Techne Validates Climate Targets, Cuts Emissions 49% in 2026
Event summary
- Science Based Targets initiative validated Bio-Techne's Scope 1, 2, and 3 greenhouse gas reduction targets.
- Market-based Scope 1 and 2 emissions reduced 49% year-over-year.
- More than half (51%) of Bio-Techne's electricity now comes from renewable sources.
- First comprehensive Scope 3 emissions inventory completed.
The big picture
Bio-Techne's validation by the Science Based Targets initiative underscores a broader industry shift toward stringent ESG accountability in life sciences. The company's 49% year-over-year emissions reduction and 51% renewable electricity usage reflect growing investor and regulatory pressure for measurable sustainability progress. With over $1.2 billion in net sales and 34 global locations, Bio-Techne's actions signal how mid-cap biotech firms are balancing growth with environmental responsibility.
What we're watching
- Target Execution
- Whether Bio-Techne can sustain its 49% year-over-year emissions reduction pace to meet its 70% reduction target by fiscal 2031.
- Supplier Alignment
- The pace at which Bio-Techne's suppliers adopt science-based targets, with 81% of spend-covered suppliers targeted by fiscal 2030.
- Renewable Energy Expansion
- How Bio-Techne will scale its renewable electricity usage beyond its Minneapolis headquarters and St. Paul GMP facility.
Related topics